Mesa Laboratories Appoints Dr. Siddhartha Kadia CEO Effective April 13, 2026
Mesa Laboratories CEO Gary Owens will step down on April 12, 2026, after leading the company since 2017 through market expansion and Mesa Way system implementation. Dr. Siddhartha Kadia will become CEO on April 13, 2026, bringing experience leading Calibre Scientific, PhenomeX and a $2 billion Life Technologies unit.
1. CEO Transition
On April 12, 2026, Gary Owens will step down as President and CEO of Mesa Laboratories after nearly nine years at the helm, during which he drove market expansion and implemented the Mesa Way business system. The board has appointed Dr. Siddhartha Kadia to assume the CEO role on April 13, 2026, with Owens supporting a smooth leadership handover.
2. New CEO Background
Dr. Siddhartha Kadia brings leadership experience as CEO of Calibre Scientific and PhenomeX, as well as heading a $2 billion Life Technologies business. He also led EAG Laboratories through its acquisition by Eurofins Scientific, has held senior global roles in Japan and Greater China, and served on multiple life sciences boards.
3. Strategic Outlook
The board expects Dr. Kadia’s proven ability to commercialize innovative technologies and scale complex organizations to drive Mesa’s next growth phase. His board appointment is intended to strengthen strategic decision-making and deliver long-term value for customers, employees and shareholders.